Cheapest Semaglutide Providers in 2026 — Ranked & Reviewed
Looking for the cheapest semaglutide in 2026? We ranked every legitimate telehealth provider in our database by their lowest published monthly price for semaglutide. No bait-and-switch teaser pricing — only providers that publish real, transparent costs. Compare and pick the lowest legit option below.
Lowest verified price: $25/mo381 providers compared
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
381 cheapest semaglutide providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
Needle-free and microdosed compounded GLP-1 options with lab-monitored care
From /mo$49CoverageCheck intakeMedicationsSemaglutideTirzepatide - Best Budget
budget-conscious shoppers
From /mo$93CoverageCheck intakeMedicationsSemaglutideTirzepatide - Nationwide Coverage
mainstream telehealth GLP-1 access
From /mo$99Flat at every doseCoverage50 statesMedicationsSemaglutideTirzepatide mainstream telehealth GLP-1 access
From /mo$99Coverage50 statesMedicationsSemaglutideTirzepatideshoppers who want low-cost, physician-led compounded GLP-1 with peptide and hormone options
From /mo$99Coverage50 statesMedicationsSemaglutideTirzepatidepatients who want the option to switch between compounded and brand-name GLP-1 through one provider
From /mo$99Coverage48 statesMedicationsSemaglutideTirzepatideoral-lozenge compounded GLP-1 access
From /mo$99Coverage49 statesMedicationsSemaglutideTirzepatidebudget-conscious shoppers
From /mo$99Flat at every doseCoverage50 statesMedicationsSemaglutideTirzepatide
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick Needle-free and microdosed compounded GLP-1 options with lab-monitored care | $49 | SemaglutideTirzepatide | Check intake | Visit → | |
Best Budget budget-conscious shoppers | $93 | SemaglutideTirzepatide | Check intake | Visit → | |
Nationwide Coverage mainstream telehealth GLP-1 access | $99 Flat pricing | SemaglutideTirzepatide | 50 states | Visit → | |
 mainstream telehealth GLP-1 access | $99 | SemaglutideTirzepatide | 50 states | Visit → | |
 shoppers who want low-cost, physician-led compounded GLP-1 with peptide and hormone options | $99 | SemaglutideTirzepatide | 50 states | Visit → | |
 patients who want the option to switch between compounded and brand-name GLP-1 through one provider | $99 | SemaglutideTirzepatide | 48 states | Visit → | |
 oral-lozenge compounded GLP-1 access | $99 | SemaglutideTirzepatide | 49 states | Visit → | |
 budget-conscious shoppers | $99 Flat pricing | SemaglutideTirzepatide | 50 states | Visit → |
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
Telos Rx
Verified partnerBest for: Needle-free and microdosed compounded GLP-1 options with lab-monitored care
Telos Rx is a compounded telehealth platform (Superior Health Solutions LLC) offering GLP-1 weight loss alongside longevity, recovery, and sexual-health peptides. Its GLP-1 line includes compounded semaglutide and tirzepatide injections plus needle-free sublingual and microdosed tirzepatide, with provider dose adjustments, lab monitoring, free discreet shipping, FSA/HSA, and cancel-anytime. Headline prices are first-month intro rates (from $49); ongoing cost is higher. Compounded meds are not FDA-approved; pharmacy and states unpublished; no LegitScript shown.
Score Breakdown
Pros
- ✓Multiple GLP-1 modalities: compounded semaglutide and tirzepatide injections plus needle-free sublingual and microdosed tirzepatide
- ✓Provider-led dose adjustments and lab monitoring as your protocol changes
- ✓Free discreet, temperature-controlled shipping (no Telos branding on the outside)
- ✓FSA/HSA eligible and cancel anytime in one click
- ✓Trustpilot rating of 4.9; full compliance suite published (Privacy, Terms, HIPAA, Shipping & returns)
- ✓Integrated care team spanning weight loss, longevity, recovery, and sexual health (peptide-led)
Cons
- ✗Headline pricing is 'first month low as' intro pricing (semaglutide $49, tirzepatide $99) — ongoing monthly cost is higher and shown during intake
- ✗Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- ✗Compounding pharmacy partner is not named
- ✗State-availability list is not published
- ✗No LegitScript certification displayed
GobyMeds
Verified partnerBest for: budget-conscious shoppers
Affordable telehealth provider offering compounded semaglutide only.
Score Breakdown
Pros
- ✓Aggressively low monthly pricing
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
bmiMD
Verified partnerBest for: mainstream telehealth GLP-1 access
Medical weight loss clinic offering GLP-1 prescriptions through telehealth.
Score Breakdown
Pros
- ✓Both semaglutide and tirzepatide available
Cons
- ✗Pricing not publicly disclosed
Found
Verified partnerBest for: mainstream telehealth GLP-1 access
Personalized weight care platform with a self-pay membership model plus medication costs.
Score Breakdown
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Live Vital
Verified partnerBest for: shoppers who want low-cost, physician-led compounded GLP-1 with peptide and hormone options
Live Vital is a physician-led telehealth practice founded by Dr. Patrick Taylor, MD, offering compounded GLP-1 weight loss — semaglutide from $99/mo and tirzepatide from $183/mo, billed as 3-month programs — alongside peptide and hormone therapy. Every plan is doctor-prescribed, filled by a licensed US pharmacy, and shipped to your door, with unlimited care-team messaging and no lock-in. Fully telehealth in all 50 states.
Score Breakdown
Pros
- ✓Physician-led — founded by Dr. Patrick Taylor, MD; all treatments doctor-prescribed via the clinical team
- ✓Transparent published pricing: semaglutide from $99/mo, tirzepatide from $183/mo (billed as 3-month programs)
- ✓Every plan includes doctor prescribing, licensed-pharmacy medication, and direct-to-door shipping
- ✓Unlimited messaging with the care team; cancel or pause anytime with no lock-in
- ✓Fully telehealth in all 50 states
Cons
- ✗Sold as 3-month programs (semaglutide $299 / tirzepatide $549 per quarter); 'starting at' rates can rise with dose
- ✗Doesn't accept insurance (HSA/FSA funds only)
- ✗Compounding pharmacy isn't named (only 'a licensed US pharmacy')
- ✗Also a peptide/longevity practice; those peptides are not FDA-approved (the site discloses this)
How to find the cheapest legitimate semaglutide
The lowest price only helps if the provider is trustworthy. Here's how to tell a genuinely cheap-and-legitimate semaglutide provider from a cut-rate risk.
What to look for
- Cheapest legit ≠ cheapest overall. The lowest number on a list isn't always the safest. Cross-check the price against the provider's trust score and pharmacy disclosure before you buy.
- Watch the plan length. The lowest per-month prices usually require a 3- or 12-month prepay. If you're not sure semaglutide is right for you, a slightly higher month-to-month price can be the cheaper mistake to make.
- Total cost, dose-adjusted. Confirm the price holds as your dose increases, and add any membership fee, to get the true cheapest option.
Red flags to avoid
- No named pharmacy or LegitScript listing. A legitimate compounded-GLP-1 provider names its 503A/503B pharmacy partner and carries LegitScript certification. If neither is disclosed, you can't verify what you're injecting.
- Async-only, no real clinician review. A prescriber should review your intake and be reachable for dose questions. Instant approval with no way to reach a clinician is a safety gap.
- Teaser pricing that hides the real cost. A low 'first month' price that jumps at higher doses, or a membership fee stacked on top of the medication, can double the true monthly total. Confirm the ongoing, all-in price before you pay.
- Weight-loss claims for B12, MIC, or HCG shots. Only GLP-1 injections have trial evidence for weight loss. A clinic selling B12, lipotropic, or HCG shots as a weight-loss treatment is a red flag.
Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.